Ready to place a bet on a young, ambitious colt? Three such horses are lined up and ready to bolt out of the gate this week. Clinical-stage biopharma Actuate Therapeutics (ACTU) focuses on developing new therapeutics for cancer diseases. OneStream (OS) is an AI-enabled financial/operational platform for enterprise organizations. Lineage (LCTX) is a REIT (real estate investment trust) that operates a global network of 482 temperature-controlled warehouses in critical locations.
The IPO market is gaining momentum in 2024, with over $20 billion raised in the year's first half. This revival is attributed to moderating inflation and interest rates. IPOs are exciting but chancy. If you’re not risk-averse, consider these companies and prepare to hop aboard!
Actuate Therapeutics
Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company that aims to raise $25.3 million through its IPO, which will be listed on NASDAQ as “ACTU” on July 24. They will offer 2.78 million shares at $8-$10 each. The company will use this funding for working capital and to research, develop, and conduct clinical trials for its primary therapeutic candidate, Elraglusib. This new treatment is a novel glycogen synthase kinase-3β (GSK-3β) inhibitor, shown to have enormous potential in treating cancers, individually or combined with other therapies.
OneStream
OneStream, Inc. operates an enterprise-level finance platform using AI to unify operational and financial data. The company targets CFOs to enable them to drive business strategy and execution. OneStream’s IPO is scheduled for July 24, listing on the Nasdaq Global Select Market as “OS.” They will offer 24.5 million Class A shares at $17-$19 each, expecting to raise $362.6 million for various purposes. Part of the proceeds will be used to buy LLC Units of OneStream Software LLC, just issued, as well as issued and outstanding KKR & Co LLC Units.
Lineage
Lineage, Inc., a temperature-controlled warehouse REIT, is set to debut on the Nasdaq Global Select Market as "LINE" on July 25. The company is offering 47 million shares at $70-$82 each and aims to raise $3.9 billion to repay debts and redeem preferred stock. It has facilities across North America, Europe, and Asia-Pacific regions, and it provides clients with supply chain and technology solutions to boost distribution efficiency, minimize supply chain waste, and enhance sustainability.
Neither Julie Stoller nor Stocks.News have positions in any of the companies covered in this article.
Did you find this insightful?
Bad
Just Okay
Amazing
Disclaimer: Information provided is for informational purposes only, not investment advice. We do not recommend buying or selling stocks. Stock price discussions are based on publicly available data. Readers should conduct their own research or consult a financial advisor before investing. Owners of this site have current positions in stocks mentioned thru out the site, Please Read Full Disclaimer for details Here https://app.stocks.news/page/disclaimer
Contributing Writer
As a professional writer since 2012, Julie Stoller has covered many industries, from healthcare and technology to consumer products and industrials. She has written about IPOs, spinoffs, ETFs, stock splits, commodities, legislative actions impacting investors, and macroeconomic issues. While keeping up with the latest meme stocks and trends, Julie's special interests are discovering ...